Michel Wager - Concepedia

Author

Michel Wager

Université de Poitiers ORCID

Also Known As

Chiara Villa, J. Voirin, Kira Boge, Legigan, Thibaut, M Wager, M. Wager, Michel Wager, S Milin, S. Milin, Wager, Michel

142

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Université de Poitiers Inserm Centre Hospitalier Universitaire de Poitiers Centre National de la Recherche Scientifique Université Paris Cité

About

Michel Wager is an author at Université de Poitiers specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	955
2	Cell Biology	8	8	419
3	Health Sciences	4	4	298
4	Social Sciences	1	1	47
5	Biomedical Engineering	1	1	11

Michel Wager

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Primary intracerebral malignant lymphoma: report of 248 cases B. Bataille, Vincent Delwail, Emmanuelle Menet, Journal of neurosurgery	2000	583
Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients Véronique Quillien, Audrey Lavenu, Lucie Karayan‐Tapon, Cancer	2012	200
Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods Lucie Karayan‐Tapon, Véronique Quillien, Joëlle Guilhot, Journal of Neuro-Oncology Neuro-oncologyOncologyMedicinePrognostic ValueO6-methylguanine-dna Methyltransferase Status	2009	183
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004 Luc Bauchet, Hélène Mathieu‐Daudé, Pascale Fabbro-Péray, Neuro-Oncology	2010	177
Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol Adrià Rofes, Emmanuel Mandonnet, J. Godden, Acta Neurochirurgica Neuroimaging BiomarkersAlzheimer's DiseaseHealth SciencesPsychiatryCognitive Performance	2017	107
STAT3 is essential for the maintenance of neurosphere‐initiating tumor cells in patients with glioblastomas: A potential for targeted therapy? Claire Villalva, Severine Martin‐Lannerée, Ulrich Cortes, International Journal of Cancer Tumor CellsTranscription Stat3Cancer BiologyGliomaTumor Biology	2010	103
Correlation of Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas J.-L. Blanc, Michel Wager, Joëlle Guilhot, Journal of Neuro-Oncology Epigenetic ChangePathologyClinical FeaturesHigh-grade GliomasMgmt Gene Promoter	2004	94
Brain tumors in eloquent areas: A European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis Giannantonio Spena, Philippe Schucht, Kathleen Seidel, Neurosurgical Review Neuro-oncologySurgical OncologyBrain Tumor BiologyBrain TumorsNeuroimaging	2016	88
Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence Pierre‐Olivier Guichet, Konstantin Masliantsev, Gaëlle Tachon, The Journal of Pathology	2018	86
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression Germán Reyes-Botero, Caroline Dehais, Ahmed Idbaïh, Neuro-Oncology	2013	67

Page 1